Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 31, 2023 - Issue 1
Submit an article Journal homepage
174
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Case Report: Recurrent Severe Uveitis Secondary to Primary Progressive Multiple Sclerosis Responsive to Ocrelizumab

Brad GuoDepartment of Ophthalmology, Queen Elizabeth Hospital, Adelaide, AustraliaCorrespondence[email protected]
View further author information
, MBBS, MMed &
Matthew LittleDepartment of Ophthalmology, Queen Elizabeth Hospital, Adelaide, AustraliaView further author information
, BSc, MBBS (Hon), FRANZCO
Pages 188-190 | Received 03 Feb 2021, Accepted 09 Sep 2021, Published online: 04 Nov 2021

References

  • Olsen TG, Frederiksen J. The association between multiple sclerosis and uveitis. Surv Ophthalmol. 2017;62:89–95. doi:10.1016/j.survophthal.2016.07.002.
  • Uwe P, Forrester JV. Multiple sclerosis and uveitis. In: Pleyer U, Forrester JV, eds. Essentials in Ophthalmology Uveitis and Immunological Disorders. Progress III. Berlin, Germany: Springer; 2009:55–60.
  • Biousse V, Trichet C, Bloch-Michel E, et al. Multiple sclerosis associated with uveitis in two large clinic-based series. Neurology. 1999;52:179–181. doi:10.1212/WNL.52.1.179.
  • Zein G, Berta A, Foster S. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2004;12:137–142. doi:10.1080/09273940490895344.
  • Cunningham ET, Pavesio CE, Goldstein DA, et al. Multiple sclerosis-associate uveitis. Ocul Immunol Inflamm. 2017;25:299–301. doi:10.1080/09273948.2017.1334469.
  • Montalban X, Hauser SL, Kappos L, et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med. 2017;376:209–220. doi:10.1056/NEJMoa1606468.
  • Gelfand JM, Cree BAC, Hauser SL. Ocrelizumab and other CD20 + B-cell-depleting therapies in multiple sclerosis. Neurotherapeutics. 2017;14:835–841. doi:10.1007/s13311-017-0557-4.
  • Jouve L, Benrabah R, Heron E, et al. Multiple sclerosis-related uveitis: does MS treatment affect uveitis course? Ocul Immunol Inflamm. 2017;25:302–307. doi:10.3109/09273948.2015.1125508.
  • Hedayatfar A, Falavarjani KG, Soheilian M, et al. Mycophenolate mofetil for the treatment of multiple sclerosis-associated uveitis. Ocul Immunol Inflamm. 2017;25:308–314. doi:10.1080/09273948.2016.1178302.
  • Towler HM, Lightman S. Symptomatic intraocular inflammation in multiple sclerosis. Clin Exp Ophthalmol. 2000;28:97–102. doi:10.1046/j.1442-9071.2000.00270.x.
  • Markov G, Vongpaisarnsin K, Foster CS. Immunomodulatory therapy and multiple sclerosis-associated uveitis. Invest Ophthalmol Vis Sci. 2013;54:2047.
  • Becker MD, Heiligenhaus A, Hudde T, et al. Interferon as a treatment for uveitis associated with multiple sclerosis. British J Ophthalmol. 2005;89:1254–1257. doi:10.1136/bjo.2004.061119.
  • Roemer S, Bissig A, Rocca A, et al. Efficacy of Natalizumab in intermediate uveitis related to multiple sclerosis: a case report. Klin Monbl Augenheilkd. 2018;235:476–477. doi:10.1055/s-0043-124756.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.